Blog
EMPASUG-SM 25/100/1000 Tablets – Empagliflozin 25mg, Sitagliptin 100mg & Metformin SR 1000mg for T
- 03-09-2026
Managing Type 2 Diabetes Mellitus often requires a comprehensive approach that includes a balanced diet, regular physical activity, healthy lifestyle habits, and appropriate medical treatment. When blood sugar levels remain uncontrolled, healthcare professionals may prescribe combination therapy involving medicines that work through different mechanisms to improve glycemic control.
EMPASUG-SM 25/100/1000 Tablets from Intralife contain a high-strength combination of Empagliflozin 25mg, Sitagliptin 100mg, and Metformin 1000mg Sustained Release (SR). This triple-combination formulation is designed to support improved blood glucose control in adults with Type 2 diabetes when prescribed as part of an appropriate diabetes management plan.
By combining three antidiabetic medicines with different mechanisms of action, EMPASUG-SM 25/100/1000 provides a comprehensive therapeutic approach for patients who require intensified glycemic management.
What is EMPASUG-SM 25/100/1000?
EMPASUG-SM 25/100/1000 is a high-strength oral antidiabetic tablet containing three active ingredients:
- Empagliflozin – 25mg
- Sitagliptin – 100mg
- Metformin Hydrochloride SR – 1000mg
The combination may be prescribed for adults with Type 2 Diabetes Mellitus when healthcare professionals determine that combination therapy is appropriate for improving blood sugar control.
Each medicine works differently, helping address multiple pathways involved in glucose regulation.
Understanding the Triple Combination
Empagliflozin 25mg
Empagliflozin belongs to a group of medicines known as SGLT2 inhibitors. It works by reducing the reabsorption of glucose by the kidneys, allowing excess glucose to be removed from the body through urine.
This mechanism provides an insulin-independent pathway for helping lower blood glucose levels.
Sitagliptin 100mg
Sitagliptin belongs to the DPP-4 inhibitor class of antidiabetic medicines. It helps support the body's incretin system, which plays a role in regulating insulin release and glucagon levels, particularly in response to meals.
By supporting appropriate glucose-dependent insulin activity, Sitagliptin contributes to improved blood sugar management.
Metformin 1000mg Sustained Release
Metformin is a widely used medicine for managing Type 2 diabetes. It primarily helps reduce glucose production by the liver and improves the body's response to insulin.
The sustained-release formulation is designed to release the medicine gradually, supporting convenient dosing and ongoing glucose management as prescribed.
Together, these three ingredients provide a multi-mechanism approach to glycemic control.
Indication of EMPASUG-SM 25/100/1000 Tablets
EMPASUG-SM 25/100/1000 Tablets are indicated as a high-strength triple therapy for improving glycemic control in adults with uncontrolled Type 2 Diabetes Mellitus, when prescribed by a qualified healthcare professional.
The medicine should be used alongside:
- A balanced and diabetes-appropriate diet
- Regular physical activity
- Healthy lifestyle practices
- Regular blood glucose monitoring
- Medical supervision
Medication is only one part of effective diabetes management. Long-term results also depend on maintaining healthy lifestyle habits and following the treatment plan recommended by a healthcare professional.
Key Benefits of EMPASUG-SM 25/100/1000
Comprehensive Blood Sugar Management
The combination of Empagliflozin, Sitagliptin, and Metformin works through different mechanisms to support better glycemic control.
High-Strength Triple Therapy
EMPASUG-SM 25/100/1000 provides three antidiabetic medicines in a single formulation for patients who require intensified treatment.
Multiple Mechanisms of Action
The formulation supports blood glucose management by addressing:
- Excess glucose reabsorption by the kidneys
- Glucose-dependent insulin and glucagon regulation
- Excess glucose production by the liver
- Reduced insulin sensitivity
Sustained-Release Metformin Support
The SR formulation of Metformin is designed for gradual release as prescribed, supporting continued glucose management.
Convenient Combination Therapy
A triple-drug combination in a single tablet may simplify the prescribed medication routine compared with taking multiple separate medicines.
Why Effective Glycemic Control Matters
Maintaining blood sugar within the target range recommended by a healthcare professional is an important part of Type 2 diabetes management. Persistently elevated blood glucose can contribute to long-term health complications involving various organs and systems.
Regular monitoring, appropriate medication, balanced nutrition, physical activity, and routine medical follow-up all contribute to effective diabetes management.
Treatment requirements can vary significantly between individuals. Factors such as current blood glucose levels, HbA1c results, kidney function, other medications, and overall health should be considered by the treating healthcare professional before selecting a treatment plan.
Why Choose EMPASUG-SM 25/100/1000?
EMPASUG-SM 25/100/1000 is formulated to provide a high-strength triple combination for appropriate patients with Type 2 diabetes requiring additional glycemic support.
Key features include:
- Empagliflozin 25mg
- Sitagliptin 100mg
- Metformin Hydrochloride SR 1000mg
- Triple-mechanism approach to blood sugar management
- Designed for uncontrolled Type 2 diabetes under medical supervision
- Convenient tablet formulation
- Suitable for integration into a comprehensive diabetes management plan
The formulation should be selected and used based on individual medical requirements and a qualified healthcare professional's assessment.
How to Take EMPASUG-SM 25/100/1000 Tablets
Take EMPASUG-SM 25/100/1000 exactly as prescribed by your doctor.
General guidance includes:
- Follow the prescribed dose and schedule.
- Swallow the tablet whole with water unless instructed otherwise.
- Do not crush, chew, or break a sustained-release tablet.
- Continue following your recommended diet and exercise plan.
- Monitor blood glucose as advised by your healthcare professional.
- Do not change or stop your medication without consulting your doctor.
The dosage and duration of treatment should be determined individually by the treating healthcare professional.
Important Considerations
EMPASUG-SM 25/100/1000 is a prescription medicine and should only be used under medical supervision. Before starting treatment, inform your doctor about your complete medical history and any other medicines you are taking.
Regular monitoring may be required to assess blood glucose control and determine whether the treatment remains appropriate.
Maintaining adequate hydration, following dietary recommendations, and attending scheduled medical follow-ups are important components of an overall diabetes care plan.
Frequently Asked Questions
What is EMPASUG-SM 25/100/1000 used for?
EMPASUG-SM 25/100/1000 is a high-strength triple antidiabetic combination used to help improve glycemic control in adults with Type 2 Diabetes Mellitus when prescribed by a healthcare professional.
What is the composition of EMPASUG-SM 25/100/1000?
Each tablet contains Empagliflozin 25mg, Sitagliptin 100mg, and Metformin Hydrochloride SR 1000mg.
How does EMPASUG-SM 25/100/1000 help control blood sugar?
The three medicines work through different mechanisms. Empagliflozin helps remove excess glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production and improve insulin sensitivity.
Can EMPASUG-SM 25/100/1000 be used without diet and exercise?
No. Effective Type 2 diabetes management generally includes appropriate nutrition, regular physical activity, medication when prescribed, and ongoing medical monitoring.
Should I take EMPASUG-SM 25/100/1000 without consulting a doctor?
No. This is a prescription antidiabetic medicine and should only be taken according to the advice and dosage prescribed by a qualified healthcare professional.
Conclusion
EMPASUG-SM 25/100/1000 Tablets combine Empagliflozin 25mg, Sitagliptin 100mg, and Metformin Hydrochloride SR 1000mg in a high-strength triple therapy designed to support improved glycemic control in adults with uncontrolled Type 2 Diabetes Mellitus.
With three complementary mechanisms of action, the formulation offers a comprehensive approach to blood sugar management when used under appropriate medical supervision. Along with a balanced diet, regular exercise, blood glucose monitoring, and consistent medical follow-up, EMPASUG-SM 25/100/1000 can form part of an individualized diabetes management strategy.
For safe and effective use, always follow the dosage, dietary recommendations, and treatment plan provided by a qualified healthcare professional.